Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Moderated Blood Flow Restriction After Anterior Cruciate Ligament

NCT02911909 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.

NCT NCT02911909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02911909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Moderated Blood Flow Restriction After Anterior Cruciate Ligament
Lead sponsor
University of Missouri-Columbia
Phase
Not applicable
Overall status
Terminated
Start date
October 1, 2017
Completion date
October 21, 2019
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anterior cruciate ligament tear